Search Prime Grants

UM1TR004548

Cooperative Agreement

Overview

Grant Description
The OSU Center for Clinical and Translational Science: Advancing today's discoveries to improve health - Abtract

The Ohio State University (OSU) Center for Clinical and Translational Science (CCTS) was formed in 2007, with the vision to advance today's discoveries to improve health for all. We employed a comprehensive approach to address the full spectrum of T1-T4 science via the education and career development of a highly trained workforce integrated with a robust system of CTR resources.

We provided leadership in the CTSA Consortium through sharing of tools and methods to advance CTR; adopted innovations from other hubs; and fully engaged in CTSA Consortium activities (e.g., multisite trials). We also supported community engaged research addressing the most pressing health issues in our communities (e.g., opioid crisis, COVID-19). Yet, work remains.

Thus, we build upon unique strengths at OSU/NCH and in Ohio's communities. We have leveraged our strategic investment in data sciences, a robust environment of resources, and a vibrant CTR community to address CTS gaps and barriers. We will now address five CTS roadblocks to improve the quality, efficiency, and rigor of CTR:

(1) Need for improved efficiencies and effectiveness to advance CTR and ensure results are disseminated and implemented into healthcare;
(2) Education and training innovations do not reach the full CTR workforce, resulting in a declining and inadequately diverse CTS workforce, lacking the knowledge and skills to advance CTR;
(3) Limited authentic participation by diverse stakeholders across the research life cycle;
(4) Growth of complex datasets necessitates integration of clinical, environmental, and research data, with need for democratization of data accessibility to advance data equity; and
(5) Racial injustice, SDOH, the CTR teams we form, and interpretation of our results impact health disparities.

Applying a health equity and DEIA framework to every activity, we will pursue five aims:

Aim 1: Develop innovations in methods, approaches, and tools to address pressing roadblocks facing CTR.
Aim 2: Support training and career development of the full CTS workforce.
Aim 3: Engage voices from across academic and scientific disciplines, patients, communities, and industry to conduct CTR and CTS across the full lifecycle of the scientific process.
Aim 4: Deploy an accessible, responsive, and integrated system of research resources.
Aim 5: Democratize informatics resources by lowering the cost of entry for data access and computing resources.

With a commitment to metric-driven decision-making, we will evaluate the impact of the CCTS by applying the RE-AIM framework to inform strategic pivots over the next 7 years. This proposal reaffirms our commitment to advance CTS and expands our engagement with stakeholders to increase rigorous, impactful, and relevant CTR. We will develop, share, and adopt innovations through focused CTS to enhance CTR for the communities we serve and those we engage.

These resources, skilled workforce, and institutional strengths provide an agile foundation to facilitate rapid responses to emerging public health issues, and will ensure an equity lens is applied to all CTR so no one is left behind from the advances of CTR to improve human health.
Funding Goals
NOT APPLICABLE
Place of Performance
Columbus, Ohio 43210 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 195% from $5,622,982 to $16,593,003.
Ohio State University was awarded Advancing CTR for Health Improvement Cooperative Agreement UM1TR004548 worth $16,593,003 from National Center for Advancing Translational Sciences in August 2023 with work to be completed primarily in Columbus Ohio United States. The grant has a duration of 7 years and was awarded through assistance program 93.350 National Center for Advancing Translational Sciences. The Cooperative Agreement was awarded through grant opportunity Clinical and Translational Science Award (UM1 Clinical Trial Optional).

Status
(Ongoing)

Last Modified 9/24/25

Period of Performance
8/22/23
Start Date
7/31/30
End Date
32.0% Complete

Funding Split
$16.6M
Federal Obligation
$0.0
Non-Federal Obligation
$16.6M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to UM1TR004548

Subgrant Awards

Disclosed subgrants for UM1TR004548

Transaction History

Modifications to UM1TR004548

Additional Detail

Award ID FAIN
UM1TR004548
SAI Number
UM1TR004548-4142825935
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NR00 NIH National Center for Advancing Translational Sciences
Funding Office
75NR00 NIH National Center for Advancing Translational Sciences
Awardee UEI
DLWBSLWAJWR1
Awardee CAGE
5QH98
Performance District
OH-03
Senators
Sherrod Brown
J.D. (James) Vance

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Center for Advancing Translational Sciences, National Institutes of Health, Health and Human Services (075-0875) Health research and training Grants, subsidies, and contributions (41.0) $5,622,982 100%
Modified: 9/24/25